Objective-To assess the clinical importance of heart rate variability (HRV) in patients with idiopathic dilated cardiomyopathy (DCM). Patients and methods-Time domain analysis of 24 hour HRV was performed in 64 patients with DCM, 19 oftheir relatives with left ventricular enlargement (possible early DCM), and 33 healthy control subjects. Results-Measures of HRV were reduced in patients with DCM compared with controls (P < 0.05). HRV parameters were similar in relatives and controls. Measures of HRV were lower in DCM patients in whom progressive heart failure developed (n = 28) than in those who remained clinically stable (n = 36) during a follow up of 24 (20) months (P = 0-0001). Reduced HRV was associated with NYHA functional class, left ventricular end diastolic dimension, reduced left ventricular ejection fraction, and peak exercise oxygen consumption (P < 0.05) in all patients. DCM patients with standard deviation of normal to normal RR intervals calculated over the 24 hour period (SDNN) < 50 ms had a significantly lower survival rate free ofprogressive heart failure than those with SDNN > 50 ms (P = 0-0002, at 12 months; P = 0-0001, during overall follow up). Stepwise multiple regression analysis showed that SDNN < 50 ms identified, independently of other clinical variables, patients who were at increased risk of developing progressive heart failure (P = 0.0004).
Idiopathic dilated cardiomyopathy (DCM) is a chronic heart muscle disease characterised by a dilated and poorly contractile left ventricle. ' Patients often present late in end stage heart failure and have a poor prognosis associated with sudden death or progressive heart failure. The identification of patients at increased risk of sudden death or progressive heart failure is problematic and renmains a major management goal.
Heart rate variability2 (HRV) has been shown to be a powerful prognostic indicator after acute myocardial infarction3-7 and has recently been applied in other clinical settings. Reduced HRV has been consistently observed in patients with congestive heart failure8-'3 and a relation between changes in HRV and extent of left ventricular dysfunction was controversially reported.10 1213 Previous studies were mainly conducted in patients with chronic heart failure secondary to coronary artery disease. Little is known about the clinical value of HRV in patients with DCM and the value of reduced HRV in predicting clinical deterioration in these patients has never been reported. Consequently, this study assessed the relation between HRV and left ventricular performance in patients with DCM and examined the prognostic value of HRV in these patients.
Familial DCM is common (25%) and a high proportion of asymptomatic relatives of DCM patients have left ventricular enlargement, which may represent early DCM. 14 Thus the secondary goal of the study was to assess whether depressed HRV is present in asymptomatic relatives of DCM patients with left ventricular enlargement and whether it can serve as a potential marker of early disease in these subjects.
Patients and methods

STUDY POPULATION
From January 1988 to October 1994, 186 consecutive cases of DCM were evaluated at our centre for management of heart failure or arrhythmia. Of these patients, 150 had their 24 hour ambulatory electrocardiograms (ECGs) recorded at presentation. Patients were excluded if they had diabetes (n = 6) or systemic arterial hypertension (n = 5). Forty two patients were in atrial fibrillation, eight were in non-sinus rhythm, four had an implanted cardiac pacemaker, five had atrioventricular block, six had frequent atrial or ventricular arrhythmia, and seven recordings had technical faults, all of which precluded analysis of HRV. Three further patients younger than 18 years were excluded on the grounds of age. The remaining 64 patients formed the study population of this report (mean age 42-9 (12K1) years, range 18-0-71'8 years; 46 men).
Patients were diagnosed according to strict criteria as recommended by the WHO and the National Heart, Lung and Blood Institute. '5 16 Fifty six patients (88%) had selective coronary angiography and ventriculography, and 42 (66%) had myocardial biopsy which was assessed by light microscopy according to the Dallas criteria.'7 All patients who did not undergo angiography were diagnosed on the basis of echocardiographic criteria together with an absence of ischaemia confirmed by history, examination, and/or exercise electrocardiography. The patients were followed up for 24 (20) 
Results
CLIICAL CHARACTERISTICS
Of 64 DCM patients for whom HRV analysis was available, 28 had progressive heart failure defined as a deterioration in New York Heart Asociation (NYHA) functional class that was refractory to maximal medical therapy (21 of these received orthotopic heart transplantation, two had clinical deterioration followed by sudden cardiac death) and the other 36 patients remained clinically stable during follow up. The clinical characteristics of the 64 patients are listed in table 1. There was no sig- HEART RATE VARIABILITY All measurements of HRV and i found to be significantly reduced Table 4 Relation between mean N in study groups The sensitivity, specificity, positive predictive accuracy, and negative predictive accuracy for prediction of progressive heart failure were 46%, 97%, 93%, and 70% (P = 0-0001) respectively, when using SDNN < 50 ms as the dichotomy point. Figure 3 shows the predictive accuracies corresponding to systematically varied dichotomy points of SDNN for prediction of progressive heart failure.
SDNN and progressive heartfailure free survival
Using the cut-off point of SDNN < 50 ms, progressive heart failure free survival curves were constructed (fig 4) . The survival analysis 9±-1-showed that DCM patients with SDNN < 50 5 200 ms had a much lower progressive heart failure free survival rate compared with those with SDNN > 50 ms (23% v 82%, P = 0-0002 at 12 months; 8% v 73%, P = 0.0001 at 24 months).
Relation between mean NN interval and HRV measurements
When all study subjects were considered as a single group, mNN intervals showed a significant linear relation with all HRV parameters (r = 0-6-0-7, P = 0-0001; fig 5) . However (n = 23) another study provided conflicting >+ 5 * data.'0 All these previous studies 8-13 were conducted on patients with chronic heart failure mainly secondary to coronary artery disease. Few data exist on HRV in patients with DCM. 600 700 800 900 1000 1100 1200 Nonetheless, the results of our study are conmNN (ins) sistent with previous reports.89 13 Medication may affect HRV measurements2 and clinical outcome. However, at presentation no patient of this study was on any specific therapy which is known to alter HRV measures. During a long follow up, it would not be practical to restrict the medication in all study patients. Nevertheless, medication could not explain the reduction of HRV and its relation to clinical outcome because all patients were under similar supervision and on conventional therapy.
Although the present data expand the role of HRV as a prognostic indicator in patients with DCM, its value in prediction of sudden death or sustained ventricular tachycardia has not been specifically assessed because there were too few such cases among our patients. 
